Mustang Bio (MBIO) Expected to Announce Earnings on Monday

Mustang Bio (NASDAQ:MBIO) will likely be releasing its earnings data before the market opens on Monday, March 10th. Analysts expect Mustang Bio to post earnings of ($0.16) per share for the quarter.

Mustang Bio Stock Performance

NASDAQ:MBIO opened at $1.48 on Friday. Mustang Bio has a fifty-two week low of $1.46 and a fifty-two week high of $67.00. The company has a 50 day moving average price of $5.05 and a 200 day moving average price of $9.50. The stock has a market capitalization of $1.41 million, a P/E ratio of -0.02 and a beta of 1.82.

About Mustang Bio

Mustang Bio, Inc, a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.